John D. Lueck

2.1k total citations
33 papers, 1.6k citations indexed

About

John D. Lueck is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John D. Lueck has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John D. Lueck's work include Ion channel regulation and function (13 papers), RNA and protein synthesis mechanisms (11 papers) and Advanced biosensing and bioanalysis techniques (10 papers). John D. Lueck is often cited by papers focused on Ion channel regulation and function (13 papers), RNA and protein synthesis mechanisms (11 papers) and Advanced biosensing and bioanalysis techniques (10 papers). John D. Lueck collaborates with scholars based in United States, Australia and France. John D. Lueck's co-authors include Robert T. Dirksen, Charles A. Thornton, Thurman M. Wheeler, Maurice S. Swanson, Robert J. Osborne, Xiaoyan Lin, Krzysztof Sobczak, Joseph J. Porter, Takashi Kimura and Angela F. Dulhunty and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

John D. Lueck

31 papers receiving 1.6k citations

Peers

Countries citing papers authored by John D. Lueck

Since Specialization

Citations

This map shows the geographic impact of John D. Lueck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Lueck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Lueck more than expected).

Fields of papers citing papers by John D. Lueck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Lueck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Lueck. The network helps show where John D. Lueck may publish in the future.

Co-authorship network of co-authors of John D. Lueck

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Lueck. A scholar is included among the top collaborators of John D. Lueck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Lueck. John D. Lueck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anticodon-edited transfer RNAs (ACE-tRNAs) encoded as therapeutic nonviral minimal DNA vectors 2026 ·Nucleic Acids Research ·Joseph J. Porter, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David Allen Dean, John D. Lueck	0
2	GzESTY as an optimized cell-based assay for initial steps in GPCR deorphanization 2025 ·Nature Communications ·(unknown), Joseph J. Porter, John D. Lueck, Cesare Orlandi	0
3	ACE-tRNAs are a platform technology for suppressing nonsense mutations that cause cystic fibrosis 2025 ·Nucleic Acids Research ·(unknown), Joseph J. Porter, Sacha Spelier, (unknown), (unknown), (unknown), (unknown), (unknown), K. Coote, Martin Mense, Jeffrey M. Beekman, John D. Lueck	5
4	Mechanism-based approach in designing patient-specific combination therapies for nonsense mutation diseases 2025 ·Nucleic Acids Research ·(unknown), A.A. Bhattacharya, (unknown), Xiaonan Cui, John D. Lueck, Yale E. Goldman, Barry S. Cooperman	1
5	Optimization of ACE-tRNAs function in translation for suppression of nonsense mutations 2024 ·Nucleic Acids Research ·Joseph J. Porter, (unknown), (unknown), John D. Lueck	7
6	Engineered tRNAs efficiently suppress CDKL5 premature termination codons 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Alessio Branchini, Mirko Pinotti, Angelisa Frasca, Joseph J. Porter, John D. Lueck, Nicoletta Landsberger	4
7	A cystic fibrosis gene editing approach that is on target 2024 ·Molecular Therapy — Nucleic Acids ·Joseph J. Porter, John D. Lueck	1
8	Gene, RNA, and ASO-based therapeutic approaches in Cystic Fibrosis 2023 ·Journal of Cystic Fibrosis ·Norm Allaire, Uta Griesenbach, Batsheva Kerem, John D. Lueck, (unknown), Yifat S. Oren	15
9	Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs 2022 ·Molecular Therapy — Nucleic Acids ·(unknown), Joseph J. Porter, (unknown), (unknown), John D. Lueck	49
10	Therapeutic promise of engineered nonsense suppressor tRNAs 2021 ·Wiley Interdisciplinary Reviews - RNA ·Joseph J. Porter, (unknown), John D. Lueck	53
11	Engineered transfer RNAs for suppression of premature termination codons 2019 ·Nature Communications ·John D. Lueck, Jae Seok Yoon, Alfredo Perales‐Puchalt, (unknown), Daniel T. Infield, Mark A. Behlke, (unknown), David B. Weiner, William R. Skach, Paul B. McCray, Christopher A. Ahern	105
12	Engineered Transfer RNA Suppression of CFTR Nonsense Mutations 2018 ·Biophysical Journal ·John D. Lueck, (unknown), Daniel T. Infield, (unknown), Paul B. McCray, Christopher A. Ahern	1
13	Orthogonality of Pyrrolysine tRNA in the Xenopus oocyte 2018 ·Scientific Reports ·Daniel T. Infield, John D. Lueck, Jason D. Galpin, (unknown), Christopher A. Ahern	12
14	Cross-kingdom auxiliary subunit modulation of a voltage-gated sodium channel 2018 ·Journal of Biological Chemistry ·(unknown), Sora Lee, Lilia Leisle, John D. Lueck, Daniele Granata, Vincenzo Carnevale, Christopher A. Ahern	6
15	Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy 2012 ·Journal of Clinical Investigation ·Aaron M. Beedle, Amy Turner, Yoshiaki Saito, John D. Lueck, (unknown), (unknown), (unknown), Kevin P. Campbell	49
16	Allele-Specific Gene Silencing in Two Mouse Models of Autosomal Dominant Skeletal Myopathy 2012 ·PLoS ONE ·Ryan E. Loy, John D. Lueck, Mohammed A. Mostajo-Radji, Ellie M. Carrell, Robert T. Dirksen	20
17	Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice 2010 ·Journal of Clinical Investigation ·Renzhi Han, (unknown), Jennifer Lévy, Erik P. Rader, John D. Lueck, Dimple Bansal, Steven A. Moore, Rainer Ng, Daniel Beltrán Valero de Bernabé, John A. Faulkner, Kevin P. Campbell	79
18	Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA 2009 ·Science ·Thurman M. Wheeler, Krzysztof Sobczak, John D. Lueck, Robert J. Osborne, Xiaoyan Lin, Robert T. Dirksen, Charles A. Thornton	303
19	Muscle Chloride Channel Dysfunction in Two Mouse Models of Myotonic Dystrophy 2006 ·The Journal of General Physiology ·John D. Lueck, Ami Mankodi, Maurice S. Swanson, Charles A. Thornton, Robert T. Dirksen	90
20	Heat‐ and anesthesia‐induced malignant hyperthermia in an RyR1 knock‐in mouse 2005 ·The FASEB Journal ·Mihail G. Chelu, Sanjeewa A. Goonasekera, William J. Durham, Wei Tang, John D. Lueck, Joyce Riehl, Isaac N. Pessah, Pumin Zhang, Meenakshi B. Bhattacharjee, Robert T. Dirksen, Susan L. Hamilton	146

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact